Stroke
A stroke is a medical emergency characterized by poor blood flow to the brain, causing cell death and resulting in impaired brain function; it primarily manifests as either ischemic (lack of blood flow) or hemorrhagic (bleeding). Mitigating the risk of stroke involves maintaining healthy lifestyle habits and managing factors like blood pressure, blood sugar, cholesterol levels, and weight.
Health Outcomes
- Beneficial Clinical Effects
- Changed Functional Connectivity
- Changed Leukocyte Telomere Length
- Changed Walking Cadence
- Decreased Composite Scores
- Enhanced Aggregation Abilities
- Enhanced Folate Synthesis
- Enhanced Functional Traits
- Enhanced Neurological Disorder Management
- Enhanced Strength
- Enhanced Survival Under Stress
- Improved 6-Meter Walk Performance
- Improved 6-minute Walking Distance
- Improved Activities of Daily Living
- Improved Agility Performance
- Improved Agility and Coordination Performance
- Improved Aging-Related Changes
- Improved Analytical Accuracy
- Improved Anticoagulatory Effects
- Improved Antihypertensive Activity
- Improved Ataxia
- Improved Auto-Aggregation Capability
- Improved Barthel Index
- Improved Barthel Index Score
- Improved Blood Pressure
- Improved Blood-Brain Barrier Function
- Improved Blood-Brain Barrier Integrity
- Improved Brain Activity
- Improved Brain Function
- Improved Brain Health
- Improved Brain-Derived Neurotrophic Factor Level
- Improved Cardiovascular Disease Marker
- Improved Cardiovascular Disease Outcomes
- Improved Cardiovascular Health
- Improved Central Nervous System Function
- Improved Clinical Outcome
- Improved Clinical Outcomes
- Improved Clinical Success
- Improved Cognition
- Improved Cognitive Function
- Improved Cognitive Performance
- Improved Cognitive Score
- Improved Cognitive Screen Score
- Improved Communication
- Improved Communication Skills
- Improved Daily Activity Participation
- Improved Decision-Making Accuracy
- Improved Endothelium-Dependent Vasodilation
- Improved Event-Free Survival
- Improved Fibrinolytic Activity
- Improved Fine Motor Skills
- Improved Function Score
- Improved Functional Capacity
- Improved Functional Outcome
- Improved Functional Prognosis
- Improved Functional Recovery
- Improved Gait Speed
- Improved Gross Motor Function
- Improved Health Condition
- Improved Health Outcomes
- Improved Health Status
- Improved Health in Elderly Populations
- Improved Human Health
- Improved Imaging Findings
- Improved Knee Extensor Strength
- Improved Learning
- Improved Leg Extension Strength
- Improved Leg Strength
- Improved Lifespan
- Improved Mathematical Processing
- Improved Mean Arterial Pressure
- Improved Mini-Mental State Examination Score
- Improved Motor Function
- Improved Motor Speed
- Improved Motor Symptom
- Improved Muscle Function Recovery
- Improved Muscle Power
- Improved Neurobehavioral Function
- Improved Neurological Symptoms
- Improved Neuromuscular Power
- Improved Neuronal Survival
- Improved Neuroplasticity Biomarkers
- Improved Neuroprotection
- Improved Neurotrophic Signaling
- Improved Overall Patient Outcomes
- Improved Perceived Recovery
- Improved Performance Mastery
- Improved Physical Function
- Improved Physical Mobility
- Improved Physical Role Limitation
- Improved Power-Related Outcome
- Improved Processing Speed
- Improved Psychomotor Skill
- Improved Reaching Ability
- Improved Reaction Time
- Improved Reactive Hyperemia Index
- Improved Secondary Outcomes
- Improved Seizure Control
- Improved Self-Sufficiency
- Improved Self-assessed Disability
- Improved Simulated Game Total Completion Time
- Improved Sprint Power Output
- Improved Standing Balance
- Improved Stress-Strain Index
- Improved Stroke Outcome
- Improved Survival Rate Under Nitrite Stress
- Improved Survival at 24 Months
- Improved TBARS Levels
- Improved Thrombolytic Property
- Improved Treatment Success
- Improved Visual-Spatial Function
- Improved Visuo-Cognitive Processing
- Improved Visuospatial Constructional Skills
- Improved Walking Ability
- Improved Walking Distance
- Improved Walking Speed
- Improved Working Memory Reaction Time
- Improved n-6 to n-3 PUFA Ratio
- Incidence of Death
- Incidence of Thrombosis
- Increased Antioxidant Activity
- Increased Apolipoprotein E Levels
- Increased Cysteine Level
- Increased Days Alive and Out of Hospital
- Increased Endogenous Acrolein Formation
- Increased Endothelial Nitric Oxide Synthase Activity
- Increased Expression of Junctional Adhesion Molecule 2
- Increased General Morbidity
- Increased Homocysteine Level
- Increased Hospital Admissions
- Increased Invasive Interventions Requirement
- Increased Length
- Increased Mortality
- Increased Mortality Rate
- Increased NRF2 Levels
- Increased Nattokinase Activity
- Increased Neurogenesis
- Increased Neuronal Cell Survival
- Increased Neuronal Firing Threshold
- Increased Nrf2 Protein Content
- Increased Plasma Nitric Oxide Levels
- Increased Prefrontal Cortex Deoxygenated Hemoglobin Level
- Increased Shear Force
- Increased Systolic Blood Pressure
- Increased Tissue Necrosis
- Increased Walking Speed
- Maintained Cognitive Function
- Maintained Physical Condition
- Maintained Vigorous Locomotion
- Mitigated Adverse Physiological Processes
- Modified Resting-State Brain Connectivity
- No Change in Major Cardiovascular Event
- No Improvement in Physical Performance
- No Progression of Hydrocephalus
- No Significant Improvement in Locomotor Activity
- Prevention of Neurological Disorders
- Reduced Aging-related Changes
- Reduced All-Cause Mortality
- Reduced Angiogenesis
- Reduced Apolipoprotein B-100 to Apolipoprotein A-1 Ratio
- Reduced Brain Inflammation
- Reduced Brain Oxidative Stress
- Reduced Cadence
- Reduced Cardiovascular Dysfunction
- Reduced Cardiovascular Event
- Reduced Cardiovascular Mortality
- Reduced Cause-Specific Mortality
- Reduced Central Blood Pressure
- Reduced Central Nervous System Symptom Severity
- Reduced Cerebral Ischemia/Reperfusion Injury
- Reduced Cerebrovascular Mortality
- Reduced Choking Index
- Reduced Cognitive Fatigue
- Reduced Cognitive Function
- Reduced Cortical Spreading Depression
- Reduced Cumulative Morbidity Rates
- Reduced Cumulative Mortality
- Reduced Disability
- Reduced Disease Incidence
- Reduced Dysphagia
- Reduced Dysphagia Symptom Score
- Reduced Emergency Care Unit Stay Duration
- Reduced Fall Incidence
- Reduced Fall Risk
- Reduced Feeding Difficulties
- Reduced Folate Deficiency
- Reduced Glial Cell Activation
- Reduced HMG-CoA Reductase Inhibition
- Reduced Homocysteine Level
- Reduced Hospital Mortality Rate
- Reduced Hospital Readmission Risk
- Reduced Hospitalization Duration
- Reduced Hypertension
- Reduced INR
- Reduced In-hospital Mortality
- Reduced Incidence of Adverse Events
- Reduced Incidence of Aspiration Pneumonia
- Reduced Incidence of Cardiovascular Disease
- Reduced Intensive Care Unit Mortality
- Reduced Length of Hospitalization
- Reduced Length of Stay
- Reduced Lifespan
- Reduced Locomotor Impairment
- Reduced Morbidity
- Reduced Morbidity Rate
- Reduced Mortality
- Reduced Mortality Rate
- Reduced Mortality Rate Before Discharge
- Reduced Mortality Rate under Stress
- Reduced Mortality Risk
- Reduced Myeloperoxidase (MPO) Concentration
- Reduced National Institutes of Health Stroke Scale Score
- Reduced Neuroinflammatory Markers
- Reduced Neurological Deficit
- Reduced Neurological Symptoms
- Reduced Neuronal Death
- Reduced Non-Infectious Complication Morbidity
- Reduced Overall Mortality Rate
- Reduced Oxidative Tissue Injury
- Reduced Plasma Homocysteine Levels
- Reduced Prefrontal Cortex Oxygen Saturation
- Reduced Prefrontal Cortex Oxygenated Hemoglobin
- Reduced Prefrontal Cortex Total Hemoglobin Level
- Reduced Reaction Time
- Reduced Recurrence Risk
- Reduced Response Time
- Reduced Serum Homocysteine Levels
- Reduced Short-term Mortality
- Reduced Simple Reaction Time
- Reduced Soluble VCAM-1 Levels
- Reduced Stroke-Like Episode Severity
- Reduced Survival Rate
- Reduced Swimming Time
- Reduced Thrombosis
- Reduced Time to Crisis Resolution
- Reduced Vascular Damage
- Reduced Walking Time
- Regulated Blood Pressure
- Regulated Microglial Activation
- Stabilized Neurofilament Light Chain Level
- Stable Long-Term Function
- Supported Physiological Function in Elderly
- Unchanged Survival Rate